Rate of virologic failure and selection of drug resistance mutations using different triple nucleos(t)ide analogue combinations in HIV-infected patients.
about
The K65R mutation in HIV-1 reverse transcriptase: genetic barriers, resistance profile and clinical implications.Development of an optimized dose for coformulation of zidovudine with drugs that select for the K65R mutation using a population pharmacokinetic and enzyme kinetic simulation model.Prevalence of K65R in patients treated with tenofovir disoproxil fumarate: recommendations based on the Frankfurt HIV Cohort Study Resistance Database (FHCS-RD).A model for reduced HIV-1 viral load monitoring in resource-limited settings.
P2860
Rate of virologic failure and selection of drug resistance mutations using different triple nucleos(t)ide analogue combinations in HIV-infected patients.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Rate of virologic failure and ...... ions in HIV-infected patients.
@ast
Rate of virologic failure and ...... ions in HIV-infected patients.
@en
type
label
Rate of virologic failure and ...... ions in HIV-infected patients.
@ast
Rate of virologic failure and ...... ions in HIV-infected patients.
@en
prefLabel
Rate of virologic failure and ...... ions in HIV-infected patients.
@ast
Rate of virologic failure and ...... ions in HIV-infected patients.
@en
P2093
P356
P1476
Rate of virologic failure and ...... tions in HIV-infected patients
@en
P2093
Carmen de Mendoza
Francisco Blanco
Juan González-Lahoz
Luz Martín-Carbonero
Pablo Barreiro
Paldma Gil
Teresa García-Benayas
P304
P356
10.1089/AID.2006.22.1231
P577
2006-12-01T00:00:00Z